Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thore Lorenzen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patientsThore Lorenzen
MMW Fortschritte Der Medizin|July 17, 2014
[Management of late presenters with opportunistic diseases: when and how to start ART]Albrecht Stoehr, Thore Lorenzen, Karsten Wursthorn
MMW Fortschritte Der Medizin|June 9, 2019
[Post-exposure prophylaxis: The earlier the better]Andreas Plettenberg, Frieder Kuhlendahl, Thore Lorenzen, et al.
European Journal of Medical Research|October 16, 2007
CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1Thore Lorenzen, Albrecht Stoehr, Irene Walther, et al.
Archives of Internal Medicine|May 22, 2002
Adherence to HAART: why is it so difficult?Volker Paech, Thore Lorenzen, Albrecht Stoehr, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 6, 2004
Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: diagnostic relevance of serology and PCRDirk Albrecht, Thomas Meyer, Thore Lorenzen, et al.
AIDS (London, England)|May 11, 2002
Gynaecomastia in HIV-infected men: association with effects of antiretroviral therapyVolker Paech, Thore Lorenzen, Ariane von Krosigk, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 18, 2001
Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapyDirk Albrecht, Bernhard Zöllner, Heinz-Hubert Feucht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of deathChristoph Wyen, Christian Hoffmann, Norbert Schmeisser, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
HIV/AIDS (Auckland, N.Z.)|November 19, 2011
Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patientsThore Lorenzen
MMW Fortschritte Der Medizin|July 17, 2014
[Management of late presenters with opportunistic diseases: when and how to start ART]Albrecht Stoehr, Thore Lorenzen, Karsten Wursthorn
MMW Fortschritte Der Medizin|June 9, 2019
[Post-exposure prophylaxis: The earlier the better]Andreas Plettenberg, Frieder Kuhlendahl, Thore Lorenzen, et al.
European Journal of Medical Research|October 16, 2007
CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1Thore Lorenzen, Albrecht Stoehr, Irene Walther, et al.
Archives of Internal Medicine|May 22, 2002
Adherence to HAART: why is it so difficult?Volker Paech, Thore Lorenzen, Albrecht Stoehr, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 6, 2004
Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: diagnostic relevance of serology and PCRDirk Albrecht, Thomas Meyer, Thore Lorenzen, et al.
AIDS (London, England)|May 11, 2002
Gynaecomastia in HIV-infected men: association with effects of antiretroviral therapyVolker Paech, Thore Lorenzen, Ariane von Krosigk, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 18, 2001
Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapyDirk Albrecht, Bernhard Zöllner, Heinz-Hubert Feucht, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of deathChristoph Wyen, Christian Hoffmann, Norbert Schmeisser, et al.
Pageof 1